Download Files:
Products Details
Product Description
– SARS-CoV-2-IN-51 (S-10) is a potent lead compound of Omicron fusion inhibitor. SARS-CoV-2-IN-51 inhibits Omicron and other variants with EC50s of 0.82-5.45 μM. SARS-CoV-2-IN-51 inhibits SARS-CoV-2 virus entry, by the direct interaction with S in the prefusion state[1].
Web ID
– HY-149368
Shipping
– Room temperature
Molecular Formula
– C58H85NO14
References
– [1]Liu M, et al. Optimization, and biological evaluation of 3-O-å°¾-chacotriosyl betulinic acid amide derivatives as novel small-molecule Omicron. Eur J Med Chem. 2023 Aug 5;256:115463.
Molecular Weight
– 1020.29
SMILES
– C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@H](O[C@@H]4C(C)(C)C(CC[C@]5(C)C6CCC7[C@@]5(C)CC[C@]8(C(NC9=CC=C(C=CC=C%10)C%10=C9)=O)C7[C@H](C(C)=C)CC8)[C@]6(C)CC4)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– SARS-CoV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
